Your browser doesn't support javascript.
loading
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts.
Pahalyants, Vartan; Murphy, William S; Klebanov, Nikolai; Lu, Chenyue; Theodosakis, Nicholas; Klevens, R Monina; Estir, Hossein; Lilly, Evelyn; Asgari, Maryam; Semenov, Yevgeniy R.
Afiliação
  • Pahalyants V; Department of Dermatology, Massachusetts General Hospital, Boston; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Murphy WS; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Klebanov N; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Lu C; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Theodosakis N; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Klevens RM; Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Boston.
  • Estir H; Laboratory of Computer Science, Massachusetts General Hospital, Boston; Department of Medicine, Massachusetts General Hospital, Boston.
  • Lilly E; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Asgari M; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston. Electronic address: ysemenov@mgh.harvard.edu.
J Am Acad Dermatol ; 86(1): 252-255, 2022 01.
Article em En | MEDLINE | ID: mdl-34509536
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / COVID-19 / Imunossupressores Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / COVID-19 / Imunossupressores Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article